DK0858345T3 - Anvendelse af muteiner af vildtypecytokiner som immunogener - Google Patents
Anvendelse af muteiner af vildtypecytokiner som immunogenerInfo
- Publication number
- DK0858345T3 DK0858345T3 DK96930345T DK96930345T DK0858345T3 DK 0858345 T3 DK0858345 T3 DK 0858345T3 DK 96930345 T DK96930345 T DK 96930345T DK 96930345 T DK96930345 T DK 96930345T DK 0858345 T3 DK0858345 T3 DK 0858345T3
- Authority
- DK
- Denmark
- Prior art keywords
- muteins
- cytokines
- immunogens
- wild
- type cytokines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Noise Elimination (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95RM000589A IT1277926B1 (it) | 1995-09-01 | 1995-09-01 | Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire |
| PCT/IT1996/000164 WO1997009064A1 (en) | 1995-09-01 | 1996-08-22 | Use of muteins of wild-type cytokines as immunogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0858345T3 true DK0858345T3 (da) | 2003-02-24 |
Family
ID=11403544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96930345T DK0858345T3 (da) | 1995-09-01 | 1996-08-22 | Anvendelse af muteiner af vildtypecytokiner som immunogener |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6706261B1 (da) |
| EP (1) | EP0858345B1 (da) |
| JP (1) | JP3157837B2 (da) |
| KR (1) | KR100279539B1 (da) |
| CN (1) | CN1138562C (da) |
| AT (1) | ATE226446T1 (da) |
| AU (1) | AU703300B2 (da) |
| CA (1) | CA2229045C (da) |
| DE (1) | DE69624498T2 (da) |
| DK (1) | DK0858345T3 (da) |
| ES (1) | ES2183007T3 (da) |
| HK (1) | HK1015708A1 (da) |
| IT (1) | IT1277926B1 (da) |
| MX (1) | MX9801550A (da) |
| PT (1) | PT858345E (da) |
| RU (1) | RU2182014C2 (da) |
| WO (1) | WO1997009064A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001025277A1 (en) * | 1999-10-07 | 2001-04-12 | Maxygen Aps | Single-chain antagonist polypeptides |
| FR2812813B1 (fr) * | 2000-08-09 | 2004-11-26 | Neovacs | Utilisation d'immunogenes pour traiter ou prevenir au sein des tumeurs malignes les dereglements immunitaires induits par des facteurs extracellulaires |
| IL161672A0 (en) * | 2004-04-29 | 2004-09-27 | Yeda Res & Dev | Compositions and methods for therapy of chemotherapy-induced neuropathy |
| FR2978964B1 (fr) | 2011-08-09 | 2015-02-20 | Conservatoire Nat Arts | Composition vaccinale anti-il-6 |
| WO2015024148A1 (zh) * | 2013-08-23 | 2015-02-26 | 中国科学院微生物研究所 | 异源动物细胞因子突变体疫苗 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2677654B1 (fr) | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. |
| US5338833A (en) * | 1992-07-23 | 1994-08-16 | The University Of North Carolina At Chapel Hill | Carboxy terminal IL-6 muteins |
| IT1263022B (it) * | 1992-11-06 | 1996-07-23 | Angeletti P Ist Richerche Bio | Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica. |
| IT1261787B (it) * | 1993-06-23 | 1996-06-03 | Angeletti P Ist Richerche Bio | Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. |
| AU6961796A (en) | 1995-09-12 | 1997-04-01 | Chiron Corporation | Improved interleukin-6 receptor antagonist |
-
1995
- 1995-09-01 IT IT95RM000589A patent/IT1277926B1/it active IP Right Grant
-
1996
- 1996-08-22 EP EP96930345A patent/EP0858345B1/en not_active Expired - Lifetime
- 1996-08-22 MX MX9801550A patent/MX9801550A/es not_active IP Right Cessation
- 1996-08-22 PT PT96930345T patent/PT858345E/pt unknown
- 1996-08-22 DK DK96930345T patent/DK0858345T3/da active
- 1996-08-22 RU RU98105679/14A patent/RU2182014C2/ru not_active IP Right Cessation
- 1996-08-22 CN CNB961972955A patent/CN1138562C/zh not_active Expired - Fee Related
- 1996-08-22 AT AT96930345T patent/ATE226446T1/de not_active IP Right Cessation
- 1996-08-22 ES ES96930345T patent/ES2183007T3/es not_active Expired - Lifetime
- 1996-08-22 CA CA002229045A patent/CA2229045C/en not_active Expired - Fee Related
- 1996-08-22 KR KR1019980701561A patent/KR100279539B1/ko not_active IP Right Cessation
- 1996-08-22 AU AU69428/96A patent/AU703300B2/en not_active Ceased
- 1996-08-22 JP JP51104897A patent/JP3157837B2/ja not_active Expired - Fee Related
- 1996-08-22 DE DE69624498T patent/DE69624498T2/de not_active Expired - Fee Related
- 1996-08-22 WO PCT/IT1996/000164 patent/WO1997009064A1/en active IP Right Grant
-
1999
- 1999-03-09 HK HK99100962A patent/HK1015708A1/xx not_active IP Right Cessation
-
2000
- 2000-04-27 US US09/559,950 patent/US6706261B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX9801550A (es) | 1998-05-31 |
| PT858345E (pt) | 2003-02-28 |
| CN1138562C (zh) | 2004-02-18 |
| JPH10511111A (ja) | 1998-10-27 |
| KR100279539B1 (ko) | 2001-02-01 |
| JP3157837B2 (ja) | 2001-04-16 |
| HK1015708A1 (en) | 1999-10-22 |
| AU703300B2 (en) | 1999-03-25 |
| WO1997009064A1 (en) | 1997-03-13 |
| CA2229045C (en) | 2005-10-25 |
| DE69624498T2 (de) | 2003-06-18 |
| DE69624498D1 (de) | 2002-11-28 |
| EP0858345A1 (en) | 1998-08-19 |
| US6706261B1 (en) | 2004-03-16 |
| ATE226446T1 (de) | 2002-11-15 |
| RU2182014C2 (ru) | 2002-05-10 |
| AU6942896A (en) | 1997-03-27 |
| KR19990044321A (ko) | 1999-06-25 |
| IT1277926B1 (it) | 1997-11-12 |
| EP0858345B1 (en) | 2002-10-23 |
| CN1198098A (zh) | 1998-11-04 |
| ES2183007T3 (es) | 2003-03-16 |
| ITRM950589A0 (it) | 1995-09-01 |
| CA2229045A1 (en) | 1997-03-13 |
| ITRM950589A1 (it) | 1997-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2677654B1 (fr) | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. | |
| PT966447E (pt) | Moleculas pequenas uteis no tratamento de doencas inflamatorias | |
| BR9907995A (pt) | Métodos imunológicos para modular miostatina em sujeitos vertebrados | |
| DE60332358D1 (de) | Protease-resistente modifizierte interferon alpha polypeptide | |
| ATE271063T1 (de) | Purin-l-nukleoside, deren analoga und verwendungen | |
| FI970799A (fi) | Mutanttientoroksiini, joka on tehokas ei-toksinen oraalinen adjuvantti | |
| CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| DE60322436D1 (de) | Verabreichung von capsaicinoiden | |
| DK0777482T3 (da) | Kombinationspræparat til behandling af immunsygdomme | |
| AR008799A1 (es) | Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento | |
| ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
| DK0909556T3 (da) | Rosaceae-ekstrakt som bradykininantagonist | |
| DK1082131T3 (da) | Immunoregulator | |
| BR0207528A (pt) | Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo | |
| ATE515258T1 (de) | Mukosales verabreichungssytem | |
| DK0858345T3 (da) | Anvendelse af muteiner af vildtypecytokiner som immunogener | |
| BR9815404A (pt) | Composição adjuvante para estimular uma eficiente resposta imunológica a uma substância antigênica, vacina para administração a um animal, processo para estimular uma resposta imunológica eficaz em um animal a uma substância antigênica, e, uso da composição adjuvante. | |
| DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
| ES2089286T3 (es) | Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. | |
| EE9800315A (et) | Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil | |
| YU39396A (sh) | Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija | |
| BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
| DK1227826T3 (da) | Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf | |
| ATE385809T1 (de) | Saponin-zusammensetzungen und deren verwendung |